Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb13
|
ENSMUSG00000049604.3 | homeobox B13 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb13 | mm10_chr11_97187943_97188666 | -0.40 | 2.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_104814298_104814722 | 36.35 |
Clmn |
calmin |
33639 |
0.15 |
chr6_52225788_52226610 | 31.63 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr3_55496495_55496973 | 30.88 |
Gm42607 |
predicted gene 42607 |
12946 |
0.14 |
chr13_104023291_104023737 | 28.05 |
Nln |
neurolysin (metallopeptidase M3 family) |
11059 |
0.2 |
chr9_94045936_94046194 | 26.09 |
Gm5369 |
predicted gene 5369 |
93397 |
0.09 |
chr9_29318648_29319159 | 24.33 |
Ntm |
neurotrimin |
92833 |
0.1 |
chr13_101427845_101427996 | 24.21 |
Gm36994 |
predicted gene, 36994 |
15331 |
0.2 |
chr19_53080891_53081464 | 23.23 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr4_73774316_73774478 | 22.71 |
Rasef |
RAS and EF hand domain containing |
16205 |
0.16 |
chr5_132068075_132068265 | 22.17 |
Auts2 |
autism susceptibility candidate 2 |
17761 |
0.16 |
chr2_74721927_74722168 | 22.10 |
Hoxd4 |
homeobox D4 |
69 |
0.9 |
chr9_67118947_67119232 | 21.93 |
Gm19299 |
predicted gene, 19299 |
14471 |
0.15 |
chr7_96609852_96610269 | 21.26 |
Gm15414 |
predicted gene 15414 |
19009 |
0.22 |
chr4_43364969_43365123 | 20.66 |
Rusc2 |
RUN and SH3 domain containing 2 |
16933 |
0.14 |
chr5_15734210_15734367 | 20.41 |
Speer4c |
spermatogenesis associated glutamate (E)-rich protein 4C |
20017 |
0.16 |
chr1_20863557_20864084 | 20.32 |
Gm24723 |
predicted gene, 24723 |
21154 |
0.1 |
chr8_26914178_26914456 | 20.26 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
29937 |
0.12 |
chr2_74381048_74381199 | 19.90 |
4930441J16Rik |
RIKEN cDNA 4930441J16 gene |
73406 |
0.1 |
chr2_74698677_74699049 | 19.88 |
Hoxd9 |
homeobox D9 |
1136 |
0.16 |
chr14_22609751_22609935 | 19.83 |
Lrmda |
leucine rich melanocyte differentiation associated |
13330 |
0.24 |
chr5_98842619_98842926 | 19.83 |
Bmp3 |
bone morphogenetic protein 3 |
11643 |
0.28 |
chr16_18185819_18186484 | 19.33 |
Mir6366 |
microRNA 6366 |
20981 |
0.08 |
chr16_92422877_92423243 | 19.23 |
Rcan1 |
regulator of calcineurin 1 |
22983 |
0.12 |
chr8_36668721_36669167 | 19.06 |
Dlc1 |
deleted in liver cancer 1 |
55001 |
0.16 |
chr18_78144650_78144915 | 18.97 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
2663 |
0.33 |
chr7_65484213_65484369 | 18.86 |
Gm44792 |
predicted gene 44792 |
3070 |
0.28 |
chr15_102997941_102998298 | 18.78 |
Hoxc6 |
homeobox C6 |
138 |
0.9 |
chr14_74692049_74692200 | 18.68 |
Gm9212 |
predicted gene 9212 |
25588 |
0.18 |
chr17_31432845_31433214 | 18.68 |
Pde9a |
phosphodiesterase 9A |
42 |
0.96 |
chr4_71131009_71131663 | 18.67 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr1_162037946_162038745 | 18.51 |
2810442N19Rik |
RIKEN cDNA 2810442N19 gene |
33173 |
0.12 |
chr6_52200956_52201123 | 18.48 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
85 |
0.88 |
chr17_77200158_77200549 | 18.31 |
Rpsa-ps8 |
ribosomal protein SA, pseudogene 8 |
162857 |
0.04 |
chr6_52216810_52217099 | 18.23 |
Hoxa7 |
homeobox A7 |
498 |
0.46 |
chr11_45550349_45550510 | 18.18 |
Gm12162 |
predicted gene 12162 |
81925 |
0.09 |
chr16_77914424_77914914 | 18.12 |
Gm17333 |
predicted gene, 17333 |
68065 |
0.1 |
chr8_47036614_47036956 | 18.09 |
4930579M01Rik |
RIKEN cDNA 4930579M01 gene |
1392 |
0.42 |
chr16_15295283_15295680 | 17.79 |
Gm21897 |
predicted gene, 21897 |
21977 |
0.21 |
chr1_90481315_90481666 | 17.60 |
Gm28722 |
predicted gene 28722 |
26989 |
0.19 |
chr1_140409463_140409798 | 17.54 |
Kcnt2 |
potassium channel, subfamily T, member 2 |
33306 |
0.23 |
chr1_44580407_44580702 | 17.42 |
Gm37626 |
predicted gene, 37626 |
19669 |
0.19 |
chr2_64172372_64172844 | 17.41 |
Fign |
fidgetin |
74570 |
0.13 |
chr15_12515262_12515649 | 17.41 |
Pdzd2 |
PDZ domain containing 2 |
21896 |
0.19 |
chr4_5494714_5495053 | 17.41 |
Gm11782 |
predicted gene 11782 |
56340 |
0.15 |
chr5_116367217_116367368 | 17.24 |
4933424N20Rik |
RIKEN cDNA 4933424N20 gene |
14343 |
0.13 |
chr8_26852335_26852486 | 17.23 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
10411 |
0.19 |
chr5_47322598_47323043 | 17.16 |
Gm43601 |
predicted gene 43601 |
169169 |
0.04 |
chr12_79674954_79675872 | 17.02 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr8_121359343_121359849 | 16.70 |
Gm26815 |
predicted gene, 26815 |
2760 |
0.29 |
chr13_4231095_4231533 | 16.50 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
2426 |
0.22 |
chr14_14354416_14355184 | 16.50 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr18_78238166_78238597 | 16.41 |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
29287 |
0.22 |
chr19_11235141_11235292 | 16.36 |
Ms4a12 |
membrane-spanning 4-domains, subfamily A, member 12 |
2768 |
0.17 |
chr3_30977085_30977719 | 16.30 |
Gm2979 |
predicted gene 2979 |
2753 |
0.2 |
chr18_80635983_80636487 | 16.18 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
27260 |
0.15 |
chr18_12504466_12504628 | 15.99 |
Gm29200 |
predicted gene 29200 |
121 |
0.77 |
chr1_53890056_53890215 | 15.91 |
Gm24251 |
predicted gene, 24251 |
3194 |
0.26 |
chr1_106586823_106587161 | 15.87 |
Gm37053 |
predicted gene, 37053 |
19878 |
0.18 |
chr13_60435036_60435317 | 15.84 |
Gm35333 |
predicted gene, 35333 |
445 |
0.83 |
chr11_19424471_19424650 | 15.76 |
Gm12026 |
predicted gene 12026 |
40875 |
0.18 |
chr4_72389960_72390156 | 15.71 |
Gm11235 |
predicted gene 11235 |
152608 |
0.04 |
chr13_63951981_63952425 | 15.64 |
Gm7695 |
predicted gene 7695 |
5682 |
0.22 |
chr10_120720257_120720409 | 15.63 |
Gm37505 |
predicted gene, 37505 |
11482 |
0.13 |
chr1_106597920_106598310 | 15.59 |
Gm37053 |
predicted gene, 37053 |
8755 |
0.22 |
chr3_99931310_99931492 | 15.56 |
Spag17 |
sperm associated antigen 17 |
45984 |
0.16 |
chr11_70070138_70070289 | 15.54 |
Asgr1 |
asialoglycoprotein receptor 1 |
14332 |
0.08 |
chr1_105088844_105089211 | 15.50 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr14_68934600_68935507 | 15.43 |
Gm47256 |
predicted gene, 47256 |
60218 |
0.12 |
chr17_73902189_73902648 | 15.29 |
Xdh |
xanthine dehydrogenase |
2011 |
0.31 |
chr10_125961290_125962183 | 15.29 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr16_29046490_29046924 | 15.26 |
Gm8253 |
predicted gene 8253 |
95352 |
0.08 |
chr13_9151034_9151497 | 15.13 |
Gm28155 |
predicted gene 28155 |
10384 |
0.16 |
chr4_55026081_55026395 | 15.07 |
Zfp462 |
zinc finger protein 462 |
14758 |
0.24 |
chr14_89560357_89560508 | 15.07 |
Gm25415 |
predicted gene, 25415 |
146373 |
0.04 |
chr4_14745648_14745800 | 14.96 |
Lrrc69 |
leucine rich repeat containing 69 |
11121 |
0.21 |
chr6_52244822_52245088 | 14.92 |
Hoxa11os |
homeobox A11, opposite strand |
288 |
0.64 |
chr1_31364092_31364251 | 14.86 |
Gm6489 |
predicted gene 6489 |
77226 |
0.08 |
chr10_125922257_125922408 | 14.84 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
43836 |
0.2 |
chr5_107222302_107222696 | 14.81 |
Gm8145 |
predicted gene 8145 |
19124 |
0.14 |
chr11_96686839_96686993 | 14.73 |
Skap1 |
src family associated phosphoprotein 1 |
21319 |
0.16 |
chr16_30055443_30055780 | 14.62 |
Hes1 |
hes family bHLH transcription factor 1 |
8773 |
0.15 |
chr14_21462396_21462784 | 14.59 |
Gm30363 |
predicted gene, 30363 |
8831 |
0.19 |
chr18_74897508_74897936 | 14.45 |
Gm24559 |
predicted gene, 24559 |
8712 |
0.12 |
chr1_137141965_137142142 | 14.45 |
Gm25609 |
predicted gene, 25609 |
73594 |
0.1 |
chr9_51927950_51928376 | 14.44 |
Gm6980 |
predicted gene 6980 |
3498 |
0.2 |
chr4_14745264_14745415 | 14.43 |
Lrrc69 |
leucine rich repeat containing 69 |
11506 |
0.21 |
chr4_9981765_9981916 | 14.39 |
Gm11835 |
predicted gene 11835 |
22486 |
0.19 |
chr14_23638190_23638341 | 14.34 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
11924 |
0.27 |
chr14_7896790_7896982 | 14.34 |
Flnb |
filamin, beta |
12145 |
0.19 |
chr16_95848554_95849066 | 14.30 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
3040 |
0.25 |
chr8_106512511_106512806 | 14.27 |
Cdh3 |
cadherin 3 |
1767 |
0.33 |
chr4_95934415_95934724 | 14.21 |
9530080O11Rik |
RIKEN cDNA 9530080O11 gene |
32466 |
0.16 |
chr1_185308459_185308873 | 14.20 |
2010103J01Rik |
RIKEN cDNA 2010103J01 gene |
3521 |
0.11 |
chr14_79971535_79971686 | 14.19 |
Gm6999 |
predicted gene 6999 |
1360 |
0.42 |
chr10_88507825_88508238 | 14.17 |
Chpt1 |
choline phosphotransferase 1 |
3958 |
0.18 |
chr14_121247265_121247775 | 14.15 |
B930095G15Rik |
RIKEN cDNA B930095G15 gene |
1186 |
0.51 |
chr11_85713167_85713372 | 14.12 |
Bcas3os1 |
breast carcinoma amplified sequence 3, opposite strand 1 |
6475 |
0.2 |
chr9_35339922_35340376 | 14.10 |
2610105M22Rik |
RIKEN cDNA 2610105M22 gene |
22964 |
0.12 |
chr1_162187271_162187995 | 14.06 |
Dnm3os |
dynamin 3, opposite strand |
29990 |
0.13 |
chr5_119179017_119179334 | 14.01 |
Gm7538 |
predicted gene 7538 |
20843 |
0.23 |
chr12_103969871_103970197 | 13.97 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
11059 |
0.1 |
chr14_23015672_23015854 | 13.96 |
Gm10248 |
predicted gene 10248 |
78808 |
0.11 |
chr8_27059625_27060031 | 13.94 |
Plpbp |
pyridoxal phosphate binding protein |
9054 |
0.1 |
chr14_23785925_23786295 | 13.79 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
17194 |
0.27 |
chr14_99280961_99281121 | 13.77 |
Gm4412 |
predicted gene 4412 |
10595 |
0.18 |
chr10_45140723_45141095 | 13.76 |
Popdc3 |
popeye domain containing 3 |
37189 |
0.13 |
chr13_31326461_31326896 | 13.67 |
Gm11373 |
predicted gene 11373 |
4089 |
0.21 |
chr3_40211928_40212079 | 13.60 |
1700017G19Rik |
RIKEN cDNA 1700017G19 gene |
297771 |
0.01 |
chr18_73267369_73267520 | 13.60 |
n-R5-8s1 |
nuclear encoded rRNA 5.8S 1 |
266106 |
0.02 |
chr8_92114786_92115008 | 13.57 |
Gm45332 |
predicted gene 45332 |
43369 |
0.13 |
chr17_36897864_36898191 | 13.51 |
Trim31 |
tripartite motif-containing 31 |
91 |
0.92 |
chr11_94880892_94881501 | 13.50 |
A430060F13Rik |
RIKEN cDNA A430060F13 gene |
19437 |
0.11 |
chr1_127214756_127215097 | 13.38 |
Mgat5 |
mannoside acetylglucosaminyltransferase 5 |
9898 |
0.2 |
chr1_45676156_45676307 | 13.36 |
Gm23216 |
predicted gene, 23216 |
9331 |
0.2 |
chr14_25042320_25042565 | 13.36 |
Gm47907 |
predicted gene, 47907 |
11345 |
0.18 |
chr16_57484144_57484357 | 13.31 |
Filip1l |
filamin A interacting protein 1-like |
64992 |
0.11 |
chr17_14493963_14494197 | 13.20 |
Gm38551 |
predicted gene, 38551 |
44509 |
0.15 |
chr11_45838507_45838961 | 13.16 |
Gm22751 |
predicted gene, 22751 |
8955 |
0.14 |
chr19_42948275_42948426 | 13.13 |
Hps1 |
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
168372 |
0.03 |
chr8_26594087_26594265 | 13.07 |
Gm39149 |
predicted gene, 39149 |
14374 |
0.17 |
chr11_66366803_66367187 | 13.07 |
Shisa6 |
shisa family member 6 |
135819 |
0.05 |
chr16_15085564_15085890 | 13.03 |
Gm49536 |
predicted gene, 49536 |
85405 |
0.08 |
chr13_104329952_104330264 | 12.98 |
Adamts6 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
22761 |
0.22 |
chr4_63032553_63033019 | 12.92 |
Zfp618 |
zinc finger protein 618 |
67212 |
0.09 |
chr6_72465653_72465804 | 12.79 |
Mat2a |
methionine adenosyltransferase II, alpha |
26170 |
0.1 |
chr9_17675645_17676038 | 12.77 |
Gm48848 |
predicted gene, 48848 |
43222 |
0.16 |
chr8_68083582_68084113 | 12.72 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
21561 |
0.24 |
chr10_99353976_99354149 | 12.70 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
48728 |
0.1 |
chr2_155862819_155863001 | 12.63 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
11218 |
0.11 |
chr14_46567129_46567280 | 12.60 |
Rubie |
RNA upstream of Bmp4 expressed in inner ear |
8643 |
0.13 |
chr8_35348609_35348943 | 12.56 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
26963 |
0.15 |
chr6_53942345_53942517 | 12.53 |
Cpvl |
carboxypeptidase, vitellogenic-like |
36231 |
0.15 |
chr4_58170039_58170218 | 12.53 |
Svep1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
36468 |
0.2 |
chr10_117644446_117644647 | 12.51 |
Cpm |
carboxypeptidase M |
15046 |
0.12 |
chr8_26655862_26656270 | 12.51 |
Gm32098 |
predicted gene, 32098 |
12240 |
0.16 |
chr1_57579162_57579340 | 12.51 |
Gm17929 |
predicted gene, 17929 |
15200 |
0.2 |
chr5_66098583_66098760 | 12.49 |
Rbm47 |
RNA binding motif protein 47 |
480 |
0.72 |
chr2_163289163_163289359 | 12.46 |
Tox2 |
TOX high mobility group box family member 2 |
31117 |
0.16 |
chr10_122769174_122769325 | 12.40 |
Gm47582 |
predicted gene, 47582 |
8816 |
0.15 |
chr9_85408412_85408563 | 12.38 |
Gm48833 |
predicted gene, 48833 |
10671 |
0.19 |
chr16_55143000_55143163 | 12.33 |
Zpld1 |
zona pellucida like domain containing 1 |
140156 |
0.05 |
chr9_50561774_50561947 | 12.32 |
Tex12 |
testis expressed 12 |
535 |
0.61 |
chr7_129679099_129679308 | 12.31 |
Gm33248 |
predicted gene, 33248 |
11778 |
0.21 |
chr13_45440349_45440538 | 12.31 |
Gm47455 |
predicted gene, 47455 |
9441 |
0.21 |
chr13_95836966_95837329 | 12.24 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
54610 |
0.11 |
chr6_31164912_31165355 | 12.21 |
Lncpint |
long non-protein coding RNA, Trp53 induced transcript |
1383 |
0.34 |
chr18_45779816_45779967 | 12.18 |
Gm50125 |
predicted gene, 50125 |
65307 |
0.12 |
chr1_169917486_169918020 | 12.15 |
Ccdc190 |
coiled-coil domain containing 190 |
10895 |
0.16 |
chr11_30209513_30209910 | 12.12 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
10061 |
0.25 |
chr8_74921062_74921461 | 12.09 |
Isx |
intestine specific homeobox |
47721 |
0.13 |
chr14_96392159_96392310 | 12.02 |
Gm24043 |
predicted gene, 24043 |
52721 |
0.16 |
chr16_29940215_29940415 | 12.01 |
Gm26569 |
predicted gene, 26569 |
6201 |
0.2 |
chr1_52293564_52293968 | 11.98 |
Gm5975 |
predicted gene 5975 |
4671 |
0.25 |
chr7_98957285_98957500 | 11.92 |
Uvrag |
UV radiation resistance associated gene |
13487 |
0.16 |
chr11_8765353_8765529 | 11.90 |
Gm11990 |
predicted gene 11990 |
41407 |
0.18 |
chr13_31710804_31711090 | 11.86 |
Gm25186 |
predicted gene, 25186 |
26793 |
0.16 |
chr15_93618820_93618971 | 11.84 |
Prickle1 |
prickle planar cell polarity protein 1 |
23004 |
0.21 |
chr18_13943807_13943958 | 11.83 |
Zfp521 |
zinc finger protein 521 |
27838 |
0.22 |
chr5_29212022_29212432 | 11.82 |
Gm7420 |
predicted gene 7420 |
5497 |
0.22 |
chr14_106365655_106365832 | 11.76 |
Gm48972 |
predicted gene, 48972 |
97809 |
0.06 |
chr15_28004309_28004491 | 11.76 |
Trio |
triple functional domain (PTPRF interacting) |
9037 |
0.22 |
chr1_75338096_75338249 | 11.75 |
Dnpep |
aspartyl aminopeptidase |
20182 |
0.09 |
chr1_106598312_106598468 | 11.75 |
Gm37053 |
predicted gene, 37053 |
8480 |
0.22 |
chr15_103032811_103032985 | 11.75 |
Hoxc4 |
homeobox C4 |
1497 |
0.22 |
chr9_96923843_96924011 | 11.74 |
Gm8524 |
predicted gene 8524 |
18420 |
0.14 |
chr16_38773021_38773235 | 11.73 |
Upk1b |
uroplakin 1B |
7215 |
0.14 |
chr2_4588091_4588292 | 11.71 |
Gm13179 |
predicted gene 13179 |
904 |
0.6 |
chr1_72401742_72401952 | 11.70 |
Gm15843 |
predicted gene 15843 |
57652 |
0.11 |
chr1_85163919_85164982 | 11.68 |
Gm6264 |
predicted gene 6264 |
3587 |
0.13 |
chr16_74506437_74506588 | 11.65 |
Robo2 |
roundabout guidance receptor 2 |
94687 |
0.08 |
chr16_16485604_16485955 | 11.65 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
18443 |
0.18 |
chr4_111357263_111357461 | 11.64 |
Gm12805 |
predicted gene 12805 |
36757 |
0.17 |
chr14_118283002_118283308 | 11.62 |
Gm9376 |
predicted gene 9376 |
16195 |
0.11 |
chr15_37928576_37928727 | 11.59 |
Gm3362 |
predicted pseudogene 3362 |
15141 |
0.13 |
chr1_130681895_130682046 | 11.57 |
C4bp-ps1 |
complement component 4 binding protein, pseudogene 1 |
2101 |
0.19 |
chr17_44148541_44148707 | 11.57 |
Clic5 |
chloride intracellular channel 5 |
13856 |
0.23 |
chr1_137376995_137377146 | 11.55 |
Gm23534 |
predicted gene, 23534 |
9823 |
0.25 |
chr13_6131432_6131800 | 11.51 |
Gm47548 |
predicted gene, 47548 |
57834 |
0.13 |
chr10_111923671_111923831 | 11.51 |
Gm47880 |
predicted gene, 47880 |
34737 |
0.12 |
chrX_10877865_10878215 | 11.51 |
Gm14473 |
predicted gene 14473 |
12407 |
0.26 |
chr14_76271306_76271620 | 11.49 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
20006 |
0.21 |
chr13_113775366_113775517 | 11.49 |
Gm47463 |
predicted gene, 47463 |
10826 |
0.13 |
chr6_140705195_140705604 | 11.49 |
Gm11077 |
predicted gene 11077 |
23885 |
0.17 |
chr13_100516977_100517128 | 11.48 |
Gtf2h2 |
general transcription factor II H, polypeptide 2 |
24473 |
0.11 |
chr15_103018773_103018952 | 11.47 |
Hoxc4 |
homeobox C4 |
72 |
0.93 |
chr12_106676590_106676891 | 11.46 |
4933406K04Rik |
RIKEN cDNA 4933406K04 gene |
39584 |
0.18 |
chr10_102511525_102512177 | 11.45 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
371 |
0.86 |
chr13_119613872_119614873 | 11.43 |
Gm48265 |
predicted gene, 48265 |
900 |
0.48 |
chr10_108350513_108350671 | 11.42 |
Gm23105 |
predicted gene, 23105 |
13073 |
0.19 |
chr18_58455394_58455793 | 11.42 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
100664 |
0.08 |
chr10_3769444_3769595 | 11.40 |
Plekhg1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
28854 |
0.22 |
chr13_51259220_51259624 | 11.37 |
Gm29787 |
predicted gene, 29787 |
53311 |
0.1 |
chr4_59937661_59937812 | 11.35 |
Slc46a2 |
solute carrier family 46, member 2 |
22680 |
0.13 |
chr16_44666539_44666952 | 11.33 |
Nepro |
nucleolus and neural progenitor protein |
57556 |
0.11 |
chr3_99666215_99666391 | 11.28 |
Gm22505 |
predicted gene, 22505 |
41544 |
0.19 |
chr16_88599937_88600275 | 11.26 |
Gm49688 |
predicted gene, 49688 |
8564 |
0.11 |
chr15_35533292_35533493 | 11.26 |
Gm48966 |
predicted gene, 48966 |
34851 |
0.15 |
chr14_121108419_121108777 | 11.24 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
6519 |
0.3 |
chr13_3708998_3709226 | 11.21 |
Gm47695 |
predicted gene, 47695 |
50713 |
0.09 |
chr4_68612420_68612574 | 11.12 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
216861 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 23.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
5.3 | 15.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
5.2 | 20.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
5.1 | 45.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
5.0 | 34.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.6 | 18.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
4.5 | 13.4 | GO:1902896 | terminal web assembly(GO:1902896) |
4.4 | 13.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
4.4 | 13.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
4.3 | 4.3 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
4.3 | 12.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.2 | 12.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
4.1 | 12.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.1 | 12.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
4.1 | 12.3 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
3.9 | 15.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
3.9 | 11.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
3.9 | 15.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.8 | 18.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.7 | 11.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
3.7 | 3.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
3.6 | 18.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
3.5 | 3.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
3.5 | 10.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
3.4 | 10.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
3.4 | 20.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
3.2 | 9.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.2 | 22.2 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) |
3.0 | 6.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
3.0 | 12.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
3.0 | 8.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.0 | 5.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.9 | 8.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.9 | 8.7 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.8 | 14.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.8 | 8.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.8 | 11.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.8 | 11.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
2.8 | 8.3 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
2.7 | 11.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.7 | 13.7 | GO:0046618 | drug export(GO:0046618) |
2.7 | 11.0 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
2.7 | 5.5 | GO:0051794 | regulation of catagen(GO:0051794) |
2.6 | 7.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.6 | 5.2 | GO:0003166 | bundle of His development(GO:0003166) |
2.6 | 7.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.5 | 10.2 | GO:0030091 | protein repair(GO:0030091) |
2.5 | 5.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.5 | 2.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.4 | 9.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.4 | 19.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.4 | 26.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
2.4 | 9.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.4 | 4.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
2.4 | 7.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
2.3 | 11.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.3 | 11.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.3 | 6.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.2 | 6.7 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
2.2 | 6.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.2 | 6.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.2 | 6.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.1 | 8.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
2.1 | 6.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.1 | 20.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.1 | 8.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
2.1 | 8.3 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
2.1 | 10.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.0 | 6.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.0 | 2.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
2.0 | 6.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.0 | 8.0 | GO:0060005 | vestibular reflex(GO:0060005) |
2.0 | 14.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
2.0 | 4.0 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.0 | 4.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.0 | 3.9 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
2.0 | 7.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.9 | 9.7 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.9 | 3.9 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.9 | 1.9 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.9 | 5.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.9 | 9.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.9 | 1.9 | GO:0048382 | mesendoderm development(GO:0048382) |
1.9 | 5.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.9 | 9.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.9 | 5.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.9 | 9.4 | GO:1904970 | brush border assembly(GO:1904970) |
1.9 | 7.4 | GO:0010288 | response to lead ion(GO:0010288) |
1.9 | 7.4 | GO:0006116 | NADH oxidation(GO:0006116) |
1.8 | 5.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.8 | 1.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.8 | 5.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.8 | 3.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.8 | 1.8 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
1.8 | 7.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.8 | 3.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
1.8 | 8.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.8 | 3.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.8 | 3.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.7 | 3.5 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.7 | 7.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.7 | 3.5 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.7 | 3.5 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.7 | 13.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.7 | 6.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.7 | 8.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.7 | 5.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.7 | 10.2 | GO:0060613 | fat pad development(GO:0060613) |
1.7 | 6.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.7 | 23.6 | GO:0003334 | keratinocyte development(GO:0003334) |
1.7 | 13.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.7 | 8.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.7 | 9.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.7 | 3.3 | GO:0003032 | detection of oxygen(GO:0003032) |
1.7 | 1.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.6 | 149.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
1.6 | 4.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.6 | 4.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.6 | 4.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.6 | 6.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.6 | 3.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.6 | 4.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.6 | 1.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.6 | 3.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.6 | 6.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.5 | 6.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.5 | 9.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.5 | 1.5 | GO:0014029 | neural crest formation(GO:0014029) |
1.5 | 3.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.5 | 5.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.5 | 14.6 | GO:0060065 | uterus development(GO:0060065) |
1.5 | 1.5 | GO:0051593 | response to folic acid(GO:0051593) |
1.4 | 4.3 | GO:0031296 | B cell costimulation(GO:0031296) |
1.4 | 4.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.4 | 1.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
1.4 | 4.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.4 | 4.3 | GO:0007494 | midgut development(GO:0007494) |
1.4 | 5.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.4 | 7.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.4 | 9.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.4 | 7.0 | GO:0006477 | protein sulfation(GO:0006477) |
1.4 | 1.4 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.4 | 2.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.4 | 4.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.4 | 2.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.3 | 9.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.3 | 5.3 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.3 | 4.0 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
1.3 | 8.0 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
1.3 | 5.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.3 | 3.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.3 | 6.4 | GO:0015884 | folic acid transport(GO:0015884) |
1.3 | 5.1 | GO:0051639 | actin filament network formation(GO:0051639) |
1.3 | 2.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.3 | 5.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 5.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.3 | 2.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 6.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.2 | 2.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.2 | 8.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.2 | 7.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.2 | 3.7 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
1.2 | 2.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.2 | 4.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.2 | 4.9 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
1.2 | 2.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.2 | 2.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.2 | 2.4 | GO:0060596 | mammary placode formation(GO:0060596) |
1.2 | 3.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.2 | 2.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 6.0 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.2 | 4.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 5.9 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
1.2 | 5.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.2 | 1.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
1.2 | 4.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.2 | 3.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.2 | 4.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 3.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.1 | 2.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.1 | 1.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.1 | 4.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.1 | 4.5 | GO:0030035 | microspike assembly(GO:0030035) |
1.1 | 5.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 3.4 | GO:0042891 | antibiotic transport(GO:0042891) |
1.1 | 3.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 3.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.1 | 1.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.1 | 3.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 2.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 14.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.1 | 4.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 8.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 3.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.1 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 3.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.1 | 3.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.1 | 3.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 4.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.1 | 3.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.1 | 3.2 | GO:0015889 | cobalamin transport(GO:0015889) |
1.1 | 2.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.1 | 3.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.1 | 3.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.1 | 1.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.1 | 3.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.1 | 10.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.0 | 4.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.0 | 5.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 1.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
1.0 | 3.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.0 | 11.4 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
1.0 | 2.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.0 | 4.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.0 | 7.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 3.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.0 | 9.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.0 | 3.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.0 | 4.0 | GO:0042737 | drug catabolic process(GO:0042737) |
1.0 | 4.0 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.0 | 4.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.0 | 2.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.0 | 3.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.0 | 8.8 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.0 | 2.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.0 | 2.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
1.0 | 3.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.0 | 3.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.0 | 19.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.0 | 3.9 | GO:0006971 | hypotonic response(GO:0006971) |
1.0 | 2.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.9 | 0.9 | GO:0003211 | cardiac ventricle formation(GO:0003211) cardiac right ventricle formation(GO:0003219) |
0.9 | 1.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.9 | 0.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.9 | 1.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 | 2.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 2.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.9 | 4.7 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.9 | 11.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.9 | 2.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.9 | 1.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 2.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 1.8 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.9 | 1.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.9 | 3.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.9 | 2.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.9 | 0.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.9 | 0.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.9 | 5.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.9 | 6.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 5.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.9 | 5.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.9 | 0.9 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.9 | 2.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.9 | 5.3 | GO:0035878 | nail development(GO:0035878) |
0.9 | 0.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.9 | 2.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 1.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.9 | 3.5 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.9 | 3.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.9 | 2.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 1.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 16.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 7.8 | GO:0043217 | myelin maintenance(GO:0043217) |
0.9 | 7.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.9 | 2.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.8 | 2.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 2.5 | GO:0050955 | thermoception(GO:0050955) |
0.8 | 1.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.8 | 2.5 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 1.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.8 | 3.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 6.7 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.8 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 3.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.8 | 1.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.8 | 1.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 3.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.8 | 0.8 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.8 | 2.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 3.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.8 | 1.6 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.8 | 2.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 0.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 4.0 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.8 | 1.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 4.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 0.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 0.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.8 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.8 | 1.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.8 | 1.6 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.8 | 4.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 4.7 | GO:0060068 | vagina development(GO:0060068) |
0.8 | 0.8 | GO:0007619 | courtship behavior(GO:0007619) |
0.8 | 3.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.8 | 2.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 3.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 2.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 1.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.8 | 1.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.8 | 0.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.8 | 2.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.8 | 3.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 2.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 1.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.8 | 1.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.8 | 0.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.8 | 3.0 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.8 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 3.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.7 | 2.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.7 | 1.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 2.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 3.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 1.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 4.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.7 | 5.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 3.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.7 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 1.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.7 | 1.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.7 | 2.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 0.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.7 | 3.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.7 | 5.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.7 | 2.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 2.2 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.7 | 2.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 0.7 | GO:0061551 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
0.7 | 4.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 1.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 0.7 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.7 | 2.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 1.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.7 | 2.8 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.7 | 0.7 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.7 | 1.4 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.7 | 2.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.7 | 2.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.7 | 4.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.7 | 1.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.7 | 2.1 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.7 | 3.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.7 | 2.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 2.7 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.7 | 2.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.7 | 2.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.7 | 2.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.7 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 4.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 4.6 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.7 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 1.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 9.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 2.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 2.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 3.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 0.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.6 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 3.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.6 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 1.3 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.6 | 1.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 0.6 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 3.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 1.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 2.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 0.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 4.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.6 | 3.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.6 | 5.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.6 | 1.9 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.6 | 1.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 1.2 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 6.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.6 | 1.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.6 | 2.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.6 | 0.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 2.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 1.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.6 | 1.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.6 | 3.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 7.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.6 | 8.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.6 | 3.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 0.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.6 | 0.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.6 | 1.2 | GO:0043366 | beta selection(GO:0043366) |
0.6 | 3.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 1.2 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.6 | 1.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 0.6 | GO:0007512 | adult heart development(GO:0007512) |
0.6 | 2.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 4.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.6 | 3.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 1.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 0.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.6 | 0.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.6 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.6 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 2.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 1.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.6 | 1.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.6 | 3.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.6 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 16.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 1.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 1.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 10.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.5 | 4.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.5 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 1.1 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.5 | 1.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 3.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.5 | 0.5 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.5 | 4.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 1.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 4.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 2.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.5 | 1.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.5 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.5 | 2.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 4.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 3.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.5 | 5.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.5 | 3.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 11.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.5 | 2.5 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.5 | 1.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 2.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 1.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 3.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 1.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 1.0 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 0.5 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.5 | 1.5 | GO:0098868 | bone growth(GO:0098868) |
0.5 | 3.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.5 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 1.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 2.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.5 | 2.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 1.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 3.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 1.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 3.4 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.5 | 2.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.5 | 1.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 2.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 1.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 2.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.5 | 0.5 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.5 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 0.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 1.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 6.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 1.4 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.5 | 1.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.5 | 2.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 1.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 0.9 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 1.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 1.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 3.2 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 0.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 1.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 3.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 4.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.4 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 0.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 0.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 0.5 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.4 | 2.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 0.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 0.9 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.4 | 2.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 0.4 | GO:0060914 | heart formation(GO:0060914) |
0.4 | 1.8 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.4 | 8.0 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.4 | 1.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 1.3 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 1.3 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.4 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 2.6 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.4 | 0.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.4 | 2.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 5.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.4 | 2.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.4 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.4 | 1.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 1.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 2.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 1.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 0.8 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 11.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.4 | 9.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.4 | 1.3 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 3.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.4 | 0.8 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.4 | 1.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.4 | 2.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.4 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 0.8 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 2.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 2.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 0.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.4 | 0.4 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.4 | 2.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 5.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 1.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 3.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.4 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 1.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 6.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 4.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 1.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.4 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 3.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 2.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.4 | 0.4 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.4 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 1.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 1.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.4 | 2.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 2.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.4 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 1.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 1.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.4 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 1.1 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 0.4 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.4 | 0.4 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 7.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.4 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 0.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.4 | 2.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.4 | 2.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 1.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 5.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.4 | 1.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 1.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 0.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.3 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 2.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.3 | 2.1 | GO:1903010 | regulation of bone development(GO:1903010) |
0.3 | 0.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 3.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 1.3 | GO:0032196 | transposition(GO:0032196) |
0.3 | 4.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 1.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.3 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.3 | 1.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 5.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 2.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 0.6 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.3 | 8.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 5.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 1.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.3 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.3 | 2.8 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.3 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 0.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 2.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 1.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 0.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.3 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.6 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 5.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 1.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.9 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 1.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.3 | GO:0072234 | metanephric nephron tubule development(GO:0072234) |
0.3 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 2.7 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 1.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 5.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 2.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 1.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.3 | 2.3 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.6 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.9 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 0.9 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 0.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 1.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 2.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 1.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.3 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.3 | 0.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.3 | 0.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 2.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 1.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.3 | 12.7 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.3 | 1.9 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.3 | 1.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.3 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.8 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.3 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 2.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 1.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 0.3 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 4.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 1.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 2.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.5 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.3 | 1.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.3 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 2.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 2.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 7.6 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 1.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 3.0 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 5.4 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 4.4 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 9.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 2.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 1.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 2.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.5 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 1.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 7.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 0.2 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.6 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 2.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 1.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 1.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.9 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 1.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 3.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 3.4 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.2 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 6.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 3.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 1.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.6 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 1.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 1.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 1.0 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 1.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 1.9 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.2 | 0.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 2.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 4.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.6 | GO:0007320 | insemination(GO:0007320) |
0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.2 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 2.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.4 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.2 | 0.2 | GO:0003321 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 1.9 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.2 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 1.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.2 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) Schwann cell proliferation(GO:0014010) |
0.2 | 2.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 12.1 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.2 | 0.7 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 3.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.2 | 0.2 | GO:0046271 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.2 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.2 | 0.3 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 3.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 9.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 4.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 0.2 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 1.1 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.2 | 0.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.8 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.1 | 0.3 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 3.3 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 1.3 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 2.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.9 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.1 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.5 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.1 | 0.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 2.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.3 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 1.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 2.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.1 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 1.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.1 | 0.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 2.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.8 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.5 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.5 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 1.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 1.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.1 | 0.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 2.5 | GO:0042476 | odontogenesis(GO:0042476) |
0.1 | 2.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.3 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 4.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.9 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.5 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.4 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.1 | GO:1903019 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.3 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 1.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 2.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.7 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 3.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 1.2 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 1.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.1 | 0.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.1 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.1 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 2.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 2.5 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 1.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 1.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.0 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.2 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 2.8 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 13.3 | GO:1990357 | terminal web(GO:1990357) |
2.6 | 7.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.4 | 9.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.4 | 7.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.3 | 11.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.3 | 27.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.1 | 12.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.0 | 5.9 | GO:0097513 | myosin II filament(GO:0097513) |
1.8 | 5.3 | GO:0044393 | microspike(GO:0044393) |
1.7 | 29.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.6 | 6.4 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.6 | 4.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 3.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.5 | 13.3 | GO:0044327 | dendritic spine head(GO:0044327) |
1.5 | 4.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.4 | 4.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.4 | 2.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 5.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.3 | 5.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.3 | 5.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 15.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.3 | 1.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 5.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.2 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 1.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.2 | 4.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.1 | 18.3 | GO:0005614 | interstitial matrix(GO:0005614) |
1.1 | 4.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.1 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
1.1 | 5.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 3.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.1 | 10.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.1 | 4.3 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 4.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 3.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.0 | 3.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 4.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 7.8 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 6.8 | GO:0000801 | central element(GO:0000801) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 12.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.9 | 0.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.9 | 6.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.9 | 13.4 | GO:0031430 | M band(GO:0031430) |
0.9 | 1.8 | GO:0042581 | specific granule(GO:0042581) |
0.9 | 49.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.9 | 3.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.8 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 1.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 8.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 3.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.8 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 7.8 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 6.2 | GO:0042641 | actomyosin(GO:0042641) |
0.8 | 3.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.8 | 2.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 8.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.7 | 4.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 13.3 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 7.3 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 4.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 2.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.7 | 2.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 2.7 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 4.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 3.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.7 | 69.0 | GO:0005903 | brush border(GO:0005903) |
0.6 | 27.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 1.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 1.2 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 1.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 5.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 3.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.6 | 0.6 | GO:0030669 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 2.3 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 4.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.5 | 4.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 6.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 9.6 | GO:0005922 | connexon complex(GO:0005922) |
0.5 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 4.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 3.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 6.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.5 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 43.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.5 | 7.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 6.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.5 | 2.0 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 2.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.5 | 2.0 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 1.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 2.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 15.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 2.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 15.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 24.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 6.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 2.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 5.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 3.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 5.7 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 0.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.4 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 2.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.4 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 3.5 | GO:0043034 | costamere(GO:0043034) |
0.3 | 2.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.7 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 1.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 4.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 2.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 16.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 1.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 2.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 4.7 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 2.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 1.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 82.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 2.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 3.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 2.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 4.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 84.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 0.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 3.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.0 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 7.0 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 3.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 10.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 2.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 1.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 5.5 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 2.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 20.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 3.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.0 | GO:0001652 | granular component(GO:0001652) |
0.2 | 17.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 2.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 9.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 14.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 1.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 7.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 22.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 8.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 7.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.3 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 150.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 5.1 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 9.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 3.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 2.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 22.7 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 3.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 5.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 3.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 1.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 62.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 1.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 6.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
4.9 | 19.8 | GO:0015265 | urea channel activity(GO:0015265) |
4.2 | 16.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.2 | 9.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.1 | 9.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
3.1 | 9.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.0 | 9.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 34.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.7 | 8.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.3 | 9.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.3 | 20.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.3 | 13.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.2 | 6.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.2 | 6.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.2 | 10.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.2 | 12.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.1 | 6.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.0 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.9 | 11.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.9 | 5.8 | GO:0004359 | glutaminase activity(GO:0004359) |
1.9 | 5.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.9 | 7.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.9 | 9.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 5.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.8 | 7.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.8 | 5.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.8 | 5.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.8 | 14.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.7 | 22.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.7 | 5.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.6 | 4.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 7.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.5 | 4.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.5 | 4.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.5 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.5 | 4.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.5 | 5.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.5 | 2.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.4 | 7.2 | GO:0070061 | fructose binding(GO:0070061) |
1.4 | 4.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 9.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.4 | 8.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.4 | 5.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.4 | 15.1 | GO:0044548 | S100 protein binding(GO:0044548) |
1.3 | 22.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.3 | 3.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.3 | 9.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.3 | 52.0 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.3 | 14.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 13.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 7.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.2 | 4.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.2 | 12.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.2 | 3.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.2 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.2 | 1.2 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.2 | 1.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.2 | 3.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.2 | 8.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 34.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.1 | 3.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.1 | 8.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.1 | 3.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 6.4 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 3.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 4.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 1.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 15.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.0 | 4.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 2.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.0 | 6.1 | GO:0039706 | co-receptor binding(GO:0039706) |
1.0 | 7.1 | GO:0034894 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 3.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.0 | 4.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.0 | 3.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 1.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.0 | 7.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.9 | 2.8 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 3.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.9 | 15.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.9 | 21.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 2.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.9 | 2.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.9 | 6.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 7.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 4.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.9 | 4.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 2.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.9 | 2.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 2.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 2.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 32.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.9 | 9.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.9 | 2.6 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.9 | 3.4 | GO:0048185 | activin binding(GO:0048185) |
0.9 | 8.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.9 | 0.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 2.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 3.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.8 | 2.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.8 | 5.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 12.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.8 | 2.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 4.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.8 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 11.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.8 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 4.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.8 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 10.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 16.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.8 | 1.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.8 | 6.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 3.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 32.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.8 | 2.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.8 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.8 | 5.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.8 | 2.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 3.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.8 | 3.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.8 | 6.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 8.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.7 | 6.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 3.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 2.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 3.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 8.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.7 | 2.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 1.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 2.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 5.7 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.7 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 4.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.8 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 3.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.7 | 2.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 5.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.7 | 4.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 2.0 | GO:0033265 | choline binding(GO:0033265) |
0.7 | 2.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.7 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 0.7 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.7 | 2.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.7 | 2.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.7 | 1.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 2.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 3.9 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 1.9 | GO:0035877 | death effector domain binding(GO:0035877) |
0.6 | 7.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.6 | 1.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 5.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.6 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 2.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 3.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 8.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 1.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 7.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 2.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.6 | 0.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.6 | 1.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 4.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 5.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.6 | 7.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 3.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 8.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 4.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 2.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 6.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 2.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 2.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 3.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 2.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 31.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.6 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 1.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 1.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 3.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 1.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 5.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.5 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.5 | 2.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.5 | 1.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.5 | 2.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 4.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 112.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 7.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 6.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 3.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 4.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.5 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 2.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 1.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 5.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 1.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.5 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 1.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 6.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 3.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 2.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 1.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 2.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.8 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 1.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.5 | 2.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 2.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 7.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 0.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 1.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 4.8 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 4.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 2.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 1.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 3.3 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 1.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 1.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 6.8 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 5.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 9.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.4 | 12.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 1.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 1.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 0.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 10.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 4.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 14.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 4.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 7.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 0.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 4.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.8 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.4 | 6.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 9.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 34.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 3.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 1.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 2.0 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 3.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 6.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 1.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 2.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.0 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 3.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 2.8 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 4.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 8.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 0.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 3.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 1.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 5.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.3 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.3 | 0.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 185.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.3 | 1.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 4.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 1.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 4.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 18.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 14.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 7.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 11.5 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 0.3 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.3 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 2.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 3.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 9.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 2.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 3.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 3.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 1.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.3 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.5 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 12.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 2.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 4.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 1.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 2.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 3.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 8.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 1.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 3.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.9 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 0.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.3 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 4.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 2.1 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.2 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.2 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 2.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 4.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 50.8 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 1.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 0.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 2.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 6.4 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 6.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 3.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 4.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.7 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 18.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 6.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 3.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 2.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 5.4 | GO:0019838 | growth factor binding(GO:0019838) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 3.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 4.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 3.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 9.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 11.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 4.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 2.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 1.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.1 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 2.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 7.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 26.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.5 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 3.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 1.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 2.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.4 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.8 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.4 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 1.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 7.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 1.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 2.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.3 | 5.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.3 | 13.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 48.5 | NABA COLLAGENS | Genes encoding collagen proteins |
1.1 | 1.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.1 | 28.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.1 | 22.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 28.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 2.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 8.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 8.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 25.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.8 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.8 | 9.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 31.0 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 11.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 27.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 23.1 | PID FGF PATHWAY | FGF signaling pathway |
0.7 | 4.0 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 10.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 9.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 10.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 24.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 1.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 16.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 13.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 7.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 19.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 2.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 5.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 13.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 9.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 2.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 11.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 71.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 13.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 15.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 4.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 7.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 17.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 1.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 7.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 3.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 103.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 6.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 10.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 5.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 3.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 4.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 1.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 5.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 2.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 1.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 5.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 2.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 4.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 37.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 5.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 7.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 5.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 2.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 6.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 37.0 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 5.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 3.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 2.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 4.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
2.2 | 2.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.0 | 15.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.9 | 35.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 21.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.6 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.4 | 4.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.2 | 17.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 11.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.1 | 11.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.1 | 23.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 30.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 20.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 12.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.9 | 46.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.9 | 31.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 3.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 12.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 1.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.8 | 3.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.8 | 8.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 6.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 2.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.7 | 7.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 15.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 5.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.6 | 7.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 6.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 9.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.6 | 4.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 9.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 15.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 54.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 7.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 1.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 1.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.5 | 13.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 5.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 3.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 3.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 1.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 6.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 4.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 18.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 3.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 3.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 13.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 4.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 6.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 9.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 5.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 3.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 5.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 3.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 1.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 5.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.4 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 7.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 9.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 6.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 1.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 1.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 1.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 7.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 9.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 4.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 0.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 4.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 3.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 22.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 3.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 1.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 4.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 13.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 2.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 13.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 4.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 4.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 1.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 22.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 3.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 5.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 2.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 4.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 4.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 3.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |